Neem Biotech Overview
- Founded
- 1998
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
- Investments
- 1
Neem Biotech General Information
Description
Developer of pharmaceutical products intended for the treatment of human, animal and plant infections. The company's pharmaceutical products include anti-infectives and antimicrobial products that are produced from marine and plant sources, enabling the treatment of human, animal and plant infections in areas of high unmet medical need and rare diseases.
Contact Information
Website
www.neembiotech.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
InQpharm Group
Primary Office
- Units G+H Roseheyworth Business Park
- Blaenau Gwent
- Abertillery NP13 1SX
- Wales, United Kingdom
+44 01495 000000
Neem Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Neem Biotech‘s full profile, request access.
Request a free trialNeem Biotech Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Graham Dixon | Head, Research & Development & Managing Director | ||
| Phil Dudfield | Chief Scientific Officer | ||
| Thomas Hafner | Executive Chairman |
Neem Biotech Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 000000 | Self | Executive Chairman | 000 0000 |
Neem Biotech Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 000000000 | Drug Discovery |